A year into a pandemic, with the introduction of life-saving vaccines, the looming threat of viral variants, and the implementation of new Biden administration policies all contributing to influence healthcare decision-makers, we have witnessed a notable shift in the paradigm of healthcare delivery.

In the first part of our Trends webinar series (now available on-demand), our experts discussed how this shift has facilitated novel collaboration between health systems, plans, and pharmaceutical manufacturers and has also led to many new opportunities–but how is the healthcare landscape responding?

How have pharmacy trends fared as a result of COVID, and what are payers doing to control costs? How has patient affordability been affected? And what new scientific and clinical therapies and treatments have emerged as a result of the pandemic?

In Part Two of our series, our subject matter experts will offer unique insights into these questions and more, as we further explore how the healthcare paradigm is shifting in 2021.

• Describe the key factors driving the rising costs of healthcare and the evolution of payer management strategies
• Identify how COVID has shifted the trajectory of pharmaceutical trends
• Summarize select scientific advancements that are poised to have a significant impact on future healthcare trends

The discussion will conclude with a live Q&A.

—

WATCH ON-DEMAND HERE!